Sandoz Irbesartan HCT(2021-01-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Sandoz Irbesartan HCT
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| HY7383 | - Recalling Firm
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Incorporated
- 110 Rue De Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| Sandoz Irbesartan HCT | DIN 02337436 | Tablet | Hydrochlorothiazide 12.5mg |
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.